I COM MEDICAL GMBH has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are ILLUSTRIS PHARMACEUTICALS INC, ONENESS BIOTECH CO and INNOVATIVE BIODEFENSE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | Republic of Korea | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Van Setten Gysbert-Botho | 11 |
#2 | Muller-Lierheim Wolfgang Georg Konrad | 5 |
#3 | Muller-Lierheim Wolfgang | 4 |
#4 | Van Setten Gysbert Botho | 2 |
#5 | Müller-Lierheim Wolfgang G K | 2 |
#6 | Muller Lierheim Wolfgang Georg Konrad | 2 |
#7 | Müller-Lierheim Wolfgang Georg Konrad | 2 |
#8 | Mueller-Lierheim Wolfgang G K | 1 |
Publication | Filing date | Title |
---|---|---|
CA3097478A1 | High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease | |
WO2019202015A1 | High molecular weight hyaluronic acid for enhancing epithelial survival and reconstitution of body surfaces | |
WO2018069763A1 | Method for establishing, restoring, and preserving homeostasis of the ocular surface | |
US2017014339A1 | Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute |